NLM Logo

blinatumomab MeSH Supplementary Concept Data 2021


MeSH Supplementary
blinatumomab
Unique ID
C510808
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C510808
Entry Term(s)
Blincyto
MEDI-538
MT-103 antibody
antibody MT-103
Pharm Action
Antineoplastic Agents
Registry Number
4FR53SIF3A
Heading Mapped to
*Antibodies, Bispecific
Frequency
321
Note
a single-chain bispecific recombinant antibody from Micromet's BiTE (bispecific T-cell engager) product platform that binds both the CD19 antigen and the T-cell receptor (CD3), for the potential treatment of B-cell lymphoma
Source
Curr Opin Mol Ther 2006 Feb;8(1):62-8
Date of Entry
2006/06/08
Revision Date
2019/10/31
blinatumomab Preferred
MT-103 antibody Narrower
Blincyto Narrower
MEDI-538 Narrower
page delivered in 0.007s